Latest News
More News
-
NMHS Innovation students win silver at Youth Think Tank Final 17 September 2024 We recently took part in the annual WA Health Youth Innovation Think Tank which invites high school students to team up with WAHealth to understand a health problem and investigate solutions. This year our North Metropolitan Health Service team from St Hilda’s Anglican School for Girls were awarded second place for their ideas to create new ways for young people to access mental health services. NMHS Innovation Director Susan Powe said the Youth Innovation Think Tank was an opportunity to empower young minds to take an active role in shaping the future of healthcare. “The event not just finds innovative solutions for today, it also equips the next generation to lead positive change in the years to come,” she said. St Hilda’s Anglican Girls School worked in teams and in partnership with NMHS clinical mentors and the Innovation Team to address the rising suicide rat... -
GEM Awards finalists announced 02 September 2024 North Metropolitan Health Service isdelighted to announce the finalists for the 2024 Go the Extra Mile (GEM) Awards. The GEM Awards are designed to recognise people and teams that go over and above to provide high quality service to our patients, the organisation and the broader community. This year we received a variety of nominations from our sites and services and would like to thank staff who took the time to put forward a colleague or team who excel in their workplace. Congratulations to the finalists from the 12 categories and all the very best for when the winners are announced on Thursday 10 October. Excellence in Clinical Care Calina Ting Leia Robinso Leo Wu Strengthening Partnerships Abortion Care Reform Team Breastfeeding Centre/Aboriginal Midwifery Group Practice Sarah Wilcox Outstanding Leader Shane Thomas Marli McGuckin and Emily Slatte... -
DonateLife WA’s Jersey Day 30 August 2024 As part of DonateLife WA's Jersey Day, we're being reminded about the importance of registering as organ and tissue donors. Organ and tissue donation can transform the lives of many Australians and could provide a loved one with a second chance at life. One organ donor can save the lives of up to seven people and help many more through eye and tissue donation. This year the National Rugby League WA (NRL WA) has thrown its support behind Jersey Day to encourage people to start a conversation with their teammates, family and friends about signing up as organ and tissue donors. For more information or to register visit the Donate Life website (external site). -
.jpg)
Potential cure for peripheral artery disease 27 August 2024 Ground-breaking results from researchers at Sir Charles Gairdner Hospital (SCGH) aims to enhance the outcomes for patients with Peripheral artery disease (PAD). PAD is a common condition affecting more than 230 million people worldwide. It involves narrowed arteries reducing blood flow most commonly to the legs and other vital organs. PAD is caused by a build-up of fatty, cholesterol-containing deposits or plaques on artery walls. Currently, around two thirds of people with end stage advanced PAD will require an amputation and approximately a fifth will have a cardiac event, such as a heart attack, in their lifetime. Vascular surgeon and Head of Department of Vascular and Endovascular Surgery at SCGH Professor Shirley Jansen and Associate Professor Juliana Hamzah have found success in a new drug that will change the trajectory of people suffering with advanced PAD. After an accumulation ... -
New treatment options inspire innovative medical research 21 August 2024 A passion for driving increased access to the latest treatments for WA patients with lymphoma and other blood cancers has guided Professor Chan Cheah in his first investigator-initiated trial. Known as LEVERAGE, this phase I/II clinical trial is looking into the potential of non-chemotherapy treatment for advanced stage follicular lymphoma patients. Professor Chan Cheah said that follicular lymphoma is the most common type of slow growing lymphoma in the Western world and we probably see 300 to 400 patients diagnosed a year in WA and thousands more living with it. Due to the significant undesirable side effects of chemotherapy, a combination of three non-chemotherapy medications – obinutuzumab, lenalidomide and venetoclax – is being reviewed to assess whether they can be part of a treatment that is effective and has a more favourable side effect profile. Prof Cheah, Clinical ...
Last Updated:
18/10/2023